Altria Group, Inc. (MO) stock analysis

Consumer Defensive · Tobacco

From the 10-K filed 2026-02-25

Business type: Franchise

How it makes money

Altria generates its earnings primarily by selling combustible cigarettes and oral tobacco products to domestic adult consumers, driven by the enduring brand strength of Marlboro.

The business operates through reportable segments that include smokeable products, oral tobacco products, and e-vapor products, alongside other activities. Substantially all revenue comes from domestic customers within the United States. Profitability is heavily propelled by the smokeable products segment, where PM USA manufactures and sells cigarettes, anchored by Marlboro, which has remained the largest-selling cigarette brand in the United States for over 50 years. Total smokeable products segment's cigarettes shipment volume reached 61.8 billion units in 2025, while oral tobacco products and e-vapor products contribute supplementary streams through brands such as Copenhagen, Skoal, on!, and NJOY.

What protects it: the moat

Management claims that strong brand equity, regulatory authorizations, and established domestic distribution protect its market position, though competitive pressures and illicit alternatives challenge these advantages.

The company relies on established flagship brands like Marlboro, Copenhagen, and Black & Mild to maintain customer loyalty despite macroeconomic headwinds and down-trading. In smoke-free categories, NJOY holds marketing granted orders from the FDA, providing a regulated product portfolio intended to safeguard against illicit market encroachment. However, management notes that the proliferation of illicit e-vapor products evading regulatory processes causes ongoing market disruption and tests the efficacy of these protective moats.

What growth costs

Altria incurs reinvestment expenses through research and development for new product platforms, joint venture funding, and strategic initiatives designed to expand its smoke-free portfolio.

The company invests in new product platforms and technologies through R&D expenditures housed within its all other category and dedicated support services provided by Altria Client Services LLC. Reinvestments are directed toward commercializing heated tobacco stick products via the Horizon joint venture with Japan Tobacco, expanding international oral tobacco capabilities, and developing non-nicotine categories. The filing does not disclose a standalone capital expenditure figure for plant and equipment maintenance versus growth.

What could damage it

A permanent acceleration of adult smokers switching to illicit e-vapor products or discount alternatives could erode cigarette shipment volumes and impair overall earnings.

Macroeconomic pressures or changing consumer preferences can drive adult nicotine consumers to down-trade to lower-priced competitive brands or purchase illicit flavored e-vapor products that evade regulatory oversight. If the operating companies cannot sufficiently raise prices to offset these volume declines, or if illicit products continue to disrupt legitimate smoke-free categories, the resulting contraction in core combustible and smoke-free margins would impair profitability and hinder the execution of the company's smoke-free transition strategy.

About Altria Group, Inc.

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. The company sells its products to distributors, as well as large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

More on MO

Other companies in Tobacco